Related Experiment Videos
Amplification of N-myc in a rhabdomyosarcoma
Abstract:
N-myc is a member of the myc oncogene family and has been thought to be specific to neurogenic cells, since it is amplified in some neuroblastomas, retinoblastomas and small-cell lung carcinomas with endocrine properties. Hybridization analyses of DNAs isolated from surgically removed tumors revealed that N-myc was amplified about 6-fold in one of the three embryonic rhabdomyosarcomas examined. The rhabdomyosarcoma containing the amplified N-myc had metastasized into bone marrow, which is preferentially involved in the metastasis of neuroblastomas but is usually not involved in the case of rhabdomyosarcomas. Since rhabdomyoblasts are derived from mesenchyme, this indicates that N-myc gene amplification is not restricted to neurogenic tumors.
Insights
The N-myc oncogene, previously thought specific to neurogenic tumors, was found amplified in an embryonic rhabdomyosarcoma. This finding expands the known roles of N-myc gene amplification in cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The N-myc oncogene, a member of the myc oncogene family, has been traditionally associated with neurogenic cell specificity.
- N-myc amplification is observed in certain neuroblastomas, retinoblastomas, and small-cell lung carcinomas with endocrine features.
Purpose of the Study:
- To investigate the presence and implications of N-myc gene amplification beyond neurogenic tumors.
- To determine if N-myc amplification occurs in non-neurogenic tumor types, specifically rhabdomyosarcomas.
Main Methods:
- Hybridization analyses were performed on DNA isolated from surgically removed tumors.
- Specific focus was placed on examining N-myc gene copy number in embryonic rhabdomyosarcomas.
Main Results:
- N-myc gene amplification, approximately 6-fold, was detected in one of three examined embryonic rhabdomyosarcomas.
- The rhabdomyosarcoma with amplified N-myc showed metastasis to the bone marrow, a pattern more typical of neuroblastomas.
- Rhabdomyoblasts originate from mesenchymal cells, indicating N-myc amplification is not exclusive to neurogenic origins.
Conclusions:
- N-myc gene amplification is not restricted solely to neurogenic tumors.
- The presence of N-myc amplification in rhabdomyosarcoma suggests a broader role in oncogenesis across different cell lineages.